[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
[ Tue, Apr 12th 2022 ]: WOPRAI
Matthew Harrison Maintained (ADCT) at Buy with Increased Target to $30 on, Apr 12th, 2022
- 🞛 This publication is a summary or evaluation of another publication
Matthew Harrison of Morgan Stanley, Maintained "ADC Therapeutics SA" (ADCT) at Buy with Increased Target from $29 to $30 on, Apr 12th, 2022.
Matthew has made no other calls on ADCT in the last 4 months.
There is 1 other peer that has a rating on ADCT. Out of the 1 peers that are also analyzing ADCT, 0 agree with Matthew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Matthew
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $54 on, Friday, March 4th, 2022